http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08157492-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 |
| filingDate | 1994-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8011fa3b6846ef557b8b703488f1852a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_531aa855f699e4f45466147673f79841 |
| publicationDate | 1996-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08157492-A |
| titleOfInvention | Anti-atherogenic peptide |
| abstract | (57) [Summary] [Objective] An object of the present invention is to provide a drug for treating a disease caused by atherosclerosis by suppressing the progress of atherosclerosis and promoting the regression. [Structure] C of apoA-I obtained by chemical synthesis or by gene recombination technology using a microorganism such as Escherichia coli or yeast or an animal cell such as CHO cell as a host Peptides on the terminal side or analogs thereof, and atherosclerosis mainly composed of the C-terminal peptide or its analogs of apoA-I excised by treating the complete molecular type apoA-I with an appropriate protease A drug for preventing or treating a disease that develops based on |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003109442-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119590-B2 |
| priorityDate | 1994-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.